NAMSAP Proposes Evidence-Based Limits on Opioids for WCMSAs

Last month, the National Alliance of Medicare Set Aside Professionals (NAMSAP) proposed evidence-based limits on opioids for Workers’ Compensation Medicare Set Aside Arrangements (WCMSA).  In a statement that has received universal support within the Medicare Secondary Payer (MSP) Compliance industry, NAMSAP has asked the Centers for Medicare and Medicaid Services (CMS) to cap the costs that have been set aside for future opioid expenditures, which will ultimately reduce the long term use of these medications.

Legacy Claim Solutions’ own Greg Gitter, currently serving as Treasurer on NAMSAP’s Board of Directors, feels this proposal is a huge first step for successful outcomes for both the insurance community and the injured workers.

“Prolonged use of these types of medications has been shown to have detrimental effects on an injured worker’s long term health,” said Gitter.  “Additionally, the costs associated with their extended use are not conducive to mutually beneficial settlements.  These guidelines, if adopted, would promote amicable resolutions which will free the injured workers’ from the workers’ compensation system, and start them down the path to a better life.”

To read the official NAMSAP press release, please click here.